
Keywords: anorectal mucosal melanoma; C-KIT inhibitors; clinical characteristics; mucosal melanoma of the head and neck; pathology; urinary tract melanoma; vulvar and vaginal mucosal melanoma; treatment; AJCC; American Joint Committee on Cancer; APR; abdominoperine